Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
52-week extension study of dutogliptin vs sitagliptin in type 2 diabetes mellitus on sulfonylurea/thiazolidinedione ± metformin background
2009-017524-36Phase 3Completed
- Sponsor
- Forest Research Institute
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dutogliptin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Forest Research Institute. Primary endpoint: Safety endpoints. Started Apr 2010; status: completed.
02
Drugs
dutogliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2009-017524-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017524-36.